Table 1.
TACE+RFA (n. 22) | TACE+Microwave (n. 45) | P value | |
---|---|---|---|
Age (years) | 58.9+ 6.4 | 58.3+ 7.8 | 0.7 |
Gender | |||
Male | 18 (81.8%) | 38 (84.4%) | 0.7 |
Female | 4 (18.2%) | 7 (15.6%) | |
Child-Pugh class | |||
Class A | 13(59.1%) | 25 (55.6%) | 0.7 |
Class B | 9 (40.9%) | 20 (44.6%) | |
Performance status | |||
0 | 8 (36.4%) | 19 (42.2%) | 0.7 |
1 | 12 (54.5%) | 20 (44.4) | |
2 | 1 (4.5%) | 5 (11.1%) | |
3 | 1(4.5%) | 1 (2.2%) | |
Serum AFP† U/ml | 49(3.7-5,470) | 35.1 (1-2,823) | 0.5 |
Number of tumors | |||
Single | 9 (40.9%) | 26 (57.8%) | 0.2 |
Two | 6 (27.3%) | 5 (11.1%) | |
Three | 7 (31.8%) | 14 (31.1%) | |
Site of tumors | |||
Left lobe | 3 (13.3%) | 5 (11.1%) | 0.9 |
Right lobe | 15 (82.2%) | 32 (71.1%) | |
Both lobes | 4 (4.4%) | 8 (17.8%) | |
Size of tumors (cm) | 4.6+1.9 | 4.2+1.9 | 0.4 |
Size of tumors | |||
≤ 3cm | 6 (28.6%) | 17 (37.8%) | 0.4 |
3-5cm | 15 (71.4%) | 28 (62.2%) |
median and range